LifeMD, Inc. (LFMDP)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

LifeMD, Inc. (LFMDP) is up 12.5% since the beginning of the year. At $24 per share, LFMDP is trading 4.5% below its 52-week high of $25.

LifeMD, Inc. (LFMDP) has returned 12.48% so far this year and 7.09% over the past 12 months.

Based on dividend-adjusted daily data since Oct 5, 2021, LFMDP's average daily return is +0.06%, while the average monthly return is +1.05%. At this rate, an investment would double in approximately 5.5 years.

Historically, 58% of months were positive and 42% were negative. The best month was Jan 2023 with a return of +18.9%, while the worst month was Jun 2022 at -13.9%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 4 months.

On a daily basis, LFMDP closed higher 45% of trading days. The best single day was Dec 16, 2021 with a return of +15.2%, while the worst single day was Nov 15, 2021 at -9.5%.

LifeMD, Inc. has an annualized alpha of 13.27%, beta of 0.13, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since October 06, 2021.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (50.60%) than losses (38.21%) - typical of diversified or defensive assets.
• Beta of 0.13 may look defensive, but with R2 of 0.01 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

LFMDP ranks 52 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for LifeMD, Inc. (LFMDP) and compare them to S&P 500 Index.

LifeMD, Inc. provided a 9.39% dividend yield over the last twelve months, with an annual payout of $2.22 per share.

The table displays the monthly dividend distributions for LifeMD, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the LifeMD, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the LifeMD, Inc. was 38.91%, occurring on Jun 27, 2022. Recovery took 256 trading sessions.

The current LifeMD, Inc. drawdown is 1.54%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of LifeMD, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how LifeMD, Inc. is priced in the market compared to other companies in the Pharmaceutical Retailers industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.